Prostate Cancer - Results from #20640

Biopsy criteria for determining appropriateness for active surveillance in the modern era - Abstract May 2, 2014

Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer - Abstract May 2, 2014

Baseline serum 25-hydroxyvitamin D levels in men undergoing radical prostatectomy: Is there an association with adverse pathologic features? - Abstract May 2, 2014

Adherence to performance measures and outcomes among men treated for prostate cancer - Abstract May 2, 2014

Unravelling the prostate-specific antigen controversy: A West of Scotland perspective - Abstract May 2, 2014

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: Population based cohort study - Abstract May 2, 2014

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer - Abstract May 2, 2014

Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer - Abstract May 2, 2014

Myriad Genetics to present three clinical studies on Prolaris® at the 2014 American Urological Association annual meeting May 2, 2014

Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: A prospective analysis of consecutive cases - Abstract May 1, 2014

Hormonal therapeutics enzalutamide and abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel-an indirect comparison - Abstract May 1, 2014

Prostate and bladder cancer: Detection of disseminated tumor cells in bone marrow - Abstract May 1, 2014

Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate - Abstract May 1, 2014

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: A systematic review and meta-analysis - Abstract May 1, 2014

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy - Abstract May 1, 2014

Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: A post hoc analysis of the randomized FinnProstate Study VII - Abstract May 1, 2014

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-Year follow-up of the ARO 96-02/AUO AP 09/95 trial - Abstract May 1, 2014

Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: Decreased likelihood of finding significant cancer on future biopsy - Abstract May 1, 2014

Improvement in clinical TNM staging documentation within a prostate cancer quality improvement collaborative - Abstract May 1, 2014

OncoGenex announces top-line survival results of phase 3 SYNERGY trial evaluating custirsen for metastatic castrate-resistant prostate cancer April 30, 2014

Page 1033 of 1435